Sol-Gel Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Sol-Gel Technologies wird ein Gewinn- und Umsatzwachstum von 26.7% bzw. 27.7% pro Jahr prognostiziert, während der Gewinn pro Aktie um 30.5% pro Jahr wachsen soll.

Wichtige Informationen

26.7%

Wachstumsrate der Gewinne

30.5%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	23.7%
Wachstumsrate der Einnahmen	27.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Feb 28

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Nov 07

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Jul 21

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Aug 04

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

May 17

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Apr 15

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Apr 05

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Nov 23

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Aug 04

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Jul 01

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Apr 27

Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

Mar 05

We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

Feb 02

What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 29

FDA accepts Sol-Gel application for Twyneo

Dec 07

Sol-Gel: Slow And Steady Topical Technology

Nov 19

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Nov 18

Sol-Gel Technologies EPS beats by $0.09, beats on revenue

Nov 12

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:SLGL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	10	-10	-10	N/A	1
12/31/2025	8	-14	-9	N/A	2
12/31/2024	13	-8	-4	N/A	1
9/30/2024	12	-10	N/A	N/A	N/A
6/30/2024	7	-15	-17	-17	N/A
3/31/2024	2	-23	N/A	N/A	N/A
12/31/2023	2	-27	-18	-18	N/A
9/30/2023	1	-28	N/A	N/A	N/A
6/30/2023	1	-26	-11	-11	N/A
3/31/2023	5	-20	N/A	N/A	N/A
12/31/2022	4	-15	-10	-9	N/A
9/30/2022	25	5	N/A	N/A	N/A
6/30/2022	33	10	-3	-3	N/A
3/31/2022	31	2	N/A	N/A	N/A
12/31/2021	31	3	-8	-8	N/A
9/30/2021	13	-17	N/A	N/A	N/A
6/30/2021	6	-27	-27	-27	N/A
3/31/2021	6	-26	N/A	N/A	N/A
12/31/2020	9	-29	-26	-25	N/A
9/30/2020	11	-29	N/A	N/A	N/A
6/30/2020	13	-28	-20	-19	N/A
3/31/2020	20	-26	N/A	N/A	N/A
12/31/2019	23	-25	-23	-22	N/A
9/30/2019	19	-30	N/A	N/A	N/A
6/30/2019	14	-30	-29	-28	N/A
3/31/2019	6	-32	N/A	N/A	N/A
12/31/2018	0	-32	-25	-23	N/A
9/30/2018	0	-26	N/A	N/A	N/A
6/30/2018	0	-32	N/A	-21	N/A
3/31/2018	0	-32	N/A	N/A	N/A
12/31/2017	0	-32	N/A	-24	N/A
9/30/2017	N/A	-31	N/A	-22	N/A
6/30/2017	N/A	-24	N/A	-22	N/A
3/31/2017	N/A	-22	N/A	N/A	N/A
12/31/2016	N/A	-21	N/A	-18	N/A
12/31/2015	N/A	-10	N/A	-8	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SLGL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: SLGL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: SLGL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: SLGLDie Einnahmen des Unternehmens (27.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: SLGLDie Einnahmen des Unternehmens (27.7% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von SLGL in 3 Jahren voraussichtlich hoch sein wird

Sol-Gel Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus revenue estimates increase by 13%, EPS downgraded

Consensus revenue estimates decrease by 15%

Consensus revenue estimates decrease by 38%, EPS upgraded

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Consensus revenue estimates decrease by 36%, EPS upgraded

Recent updates

Sol-Gel Technologies Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Less than half of directors are independent

Sol-Gel Technologies Ltd., Annual General Meeting, Aug 27, 2024

Sol-Gel Technologies Ltd. Announces Alon Seri-Levy Step Downs from His Position as CEO, Effective December 31, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Consensus revenue estimates increase by 13%, EPS downgraded

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Consensus revenue estimates decrease by 15%

Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board

Now 24% undervalued after recent price drop

Consensus revenue estimates decrease by 38%, EPS upgraded

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Consensus revenue estimates decrease by 36%, EPS upgraded

Co-Founder notifies of intention to sell stock

Sol-Gel Technologies Ltd., Annual General Meeting, Jul 26, 2023

Consensus revenue estimates increase by 42%, EPS downgraded

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates increase by 72%, EPS downgraded

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$12.50

Insufficient new directors

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 20%

Price target increased to US$19.00

Price target increased to US$18.00

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 33%

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Consensus forecasts updated

Insufficient new directors

Sol-Gel Technologies Announces FDA Approval of EPSOLAY

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO

Sol-Gel Technologies Ltd., Annual General Meeting, May 19, 2022

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates fall by 45%

Forecast to breakeven in 2021

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

Consensus forecasts updated

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Price target decreased to US$17.75

Third quarter 2021 earnings released: EPS US$0.056 (vs US$0.38 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.35 loss per share (vs US$0.31 loss in 2Q 2020)

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Consensus forecasts updated

Chief Financial Officer notifies of intention to sell stock

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Consensus revenue estimates increase to US$17.4m

Consensus forecasts updated

First quarter 2021 earnings released: US$0.18 loss per share (vs US$0.33 loss in 1Q 2020)

Forecast breakeven pushed back to 2024

Sol-Gel Technologies Provides Update on FDA Review of Epsolay®

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Analysts lower revenue estimates to US$16.8m

Full year 2020 earnings released: US$1.30 loss per share (vs US$1.26 loss in FY 2019)